RTX
RTX CorporationThesis. RTX pairs a rearmament supercycle (AMRAAM/Stinger/Patriot capacity expansions, $350B U.S. defense push) with a self-funding commercial aerospace aftermarket, delivering a perfect 4/4 earnings beat streak and +11.8% average surprise. The stock is not cheap at 26.5x forward earnings and 19.9x EV/EBITDA, and insiders were net sellers of ~$26M in February, so we accumulate on weakness toward the 200-day rather than chase the 52-week high.
Scoreboard
At $200.85 RTX commands a $270.5B market cap and $304.4B enterprise value, sitting 6.4% below its $214.50 52-week high and 40.5% above the $142.98 low — the 81st percentile of its annual range. Price trades well above both the $180.60 50-day and $184.31 200-day averages, confirming a durable uptrend. Consensus mean target of $215.14 implies only 7.1% upside, but the $220 median and $242 high point to a further leg if the defense-spending narrative holds.
QoQ Changes
Q1 2026 (Mar-31) revenue printed $22.08B, down 8.9% QoQ from Q4's $24.24B on normal seasonality, while net income rose 26.9% to $2.06B and basic EPS jumped to $1.53 from $1.21. Adjusted EPS of $1.78 beat the $1.53 consensus by 16.1%, the fourth consecutive beat.
Gross margin expanded to 20.8% in Q1 2026 from 19.5% in Q4 2025, and EBITDA margin recovered to 18.1% from 15.8%, signaling mix shift toward higher-margin defense and aftermarket volumes. Operating margin of 11.6% remains below the trailing 13.2% company average, leaving room for further conversion as production scales.
Reported FCF margin sits at 8.0%, translating to a modest 2.67% FCF yield at current prices — adequate but unremarkable for a name at this multiple. Cash generation is back-half weighted, so the trailing figure understates full-year conversion as aftermarket and missile deliveries ramp.
RTX holds $6.82B cash ($5.06/share) against $38.93B total debt, a net debt position of $32.1B and 57.2 debt-to-equity. Liquidity is tight — current ratio 1.02, quick ratio 0.65 — but easily serviced given investment-grade access and steady defense cash flows.
Shares trade at 37.8x trailing and 26.5x forward earnings, 19.9x EV/EBITDA, 3.0x sales and 4.1x book — a premium to the defense-prime cohort and to RTX's own history. The 2.76 PEG suggests the 32.5% earnings-growth rate is already substantially discounted.
Recent actions center on capacity expansion: Raytheon is doubling global Stinger output with Diehl Defence and advancing NATO/U.S.-government AMRAAM co-production feasibility studies across Europe. No major M&A or restructuring in the data window; the strategy is organic throughput expansion to meet the rearmament demand curve.
Ownership & Insider Activity
Institutions own 81.5% of the float (BlackRock 8.1%, State Street 6.9%, Vanguard 6.5%), a fortress base with negligible 0.08% insider holdings. Finnhub Form 4 data shows net insider SELLING of ~$26.0M in February 2026 — CFO Mitchill offloaded ~$7.3M via open-market sales (codes S) at ~$205.5 plus option exercises, and officer Williams sold $2.58M at $202.83, all near the 52-week high. April's transactions were exclusively director stock awards (code A) at $176.07, so the only discretionary signal — executives trimming into strength — is mildly bearish on near-term valuation.
Recent Insider Transactions
| Date | Insider | Position | Shares | Value |
|---|---|---|---|---|
| 2026-02-23 | WILLIAMS DANTAYA M | Officer | 12,713 | $2.6M |
| 2026-02-19 | MITCHILL NEIL G JR | Chief Financial Officer | 35,755 | $7.3M |
| 2026-02-19 | MAHARAJH RAMSARAN JR | General Counsel | 15,124 | $3.1M |
| 2026-02-19 | CALIO CHRISTOPHER T | Chief Executive Officer | 63,568 | $13.0M |
| 2026-02-19 | MITCHILL NEIL G JR | Chief Financial Officer | 19,394 | $1.5M |
| 2026-02-19 | CALIO CHRISTOPHER T | Chief Executive Officer | 31,199 | $2.4M |
Earnings Quality
| Period | Actual EPS | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
| 2026-03-31 Q1 | $1.78 | $1.53 | +$0.25 | +16.10% |
| 2025-12-31 Q4 | $1.55 | $1.48 | +$0.07 | +4.58% |
| 2025-09-30 Q3 | $1.70 | $1.42 | +$0.28 | +19.47% |
| 2025-06-30 Q2 | $1.56 | $1.46 | +$0.10 | +6.96% |
RTX beat consensus in 4 of the last 4 quarters with an average surprise of +11.8%, including a +19.5% blowout in Q3 2025 and +16.1% in Q1 2026 — clear evidence of a durable execution premium and conservatively set guidance.
Surprises are large and consistent rather than smoothly widening (+7.0%, +19.5%, +4.6%, +16.1%), suggesting analysts remain structurally miscalibrated to the pace of defense-backlog conversion and that upward estimate revisions likely continue.
Analyst Action
| Month | Distribution | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|---|
| 2026-07 | 7 | 13 | 8 | 1 | 1 | |
| 2026-06 | 6 | 13 | 9 | 1 | 1 | |
| 2026-05 | 6 | 13 | 8 | 2 | 1 | |
| 2026-04 | 6 | 11 | 10 | 2 | 1 |
The rating mix has drifted bullish: Strong Buy rose from 6 to 7 and Buy held at 13 between June and July 2026, while Holds ticked down from 9 to 8, leaving 20 of 30 raters at Buy-or-better against just 2 Sell/Strong Sell. Recommendation mean of 1.87 sits firmly in 'buy' territory across 22 covering analysts.
Momentum is modestly bullish — three consecutive months of positive drift with zero downgrades in the trailing 15 days.
Seven Essential Metrics
EBITDA margin 16.9% and ROE 11.6% are solid for a diversified prime but thin at the gross line (20.2%) given commercial-aerospace mix.
Revenue +8.7% YoY with earnings growth of +32.5% and quarterly EPS growth +34.1%, powered by defense demand.
FCF margin of 8.0% yields only a 2.67% FCF yield at today's price — respectable but priced-in.
$32.1B net debt and 57.2 debt-to-equity, comfortably serviced but no balance-sheet cushion (quick ratio 0.65).
Beta of just 0.30 and government-anchored revenue make RTX a low-volatility defensive; short interest is a benign 1.4% of float.
26.5x forward P/E, 19.9x EV/EBITDA and 3.0x sales sit at a premium to the defense-prime peer set and RTX's own history.
1.35B shares outstanding with active buyback capacity and a rising dividend; net effect is modestly accretive despite award-driven dilution.
A dependable, growing payout backed by defense cash flows, though yield is modest and not the core thesis.
Competitive Snapshot
| Company | EBITDA Margin | 3Y Rev CAGR | FCF Margin | Leverage | Fwd P/E |
|---|---|---|---|---|---|
LMT Lockheed Martin | ~14% | ~4% | ~8% | ~2x | ~17x |
GD General Dynamics | ~12% | ~7% | ~6% | ~1.5x | ~19x |
NOC Northrop Grumman | ~15% | ~5% | ~7% | ~2x | ~19x |
GE GE Aerospace | ~22% | ~15% | ~15% | <1x | ~34x |
RTX trades at a premium to pure defense primes LMT (~17x), GD and NOC (~19x) but a discount to GE Aerospace (~34x), reflecting its hybrid commercial-plus-defense profile. Its 32.5% earnings-growth rate meaningfully exceeds the slow-compounding primes, partly justifying the gap, though its ~17% EBITDA margin trails GE's ~22% and its net-debt position is heavier than GD/NOC. On a growth-adjusted basis RTX is the best-positioned of the primes for the missile-demand upcycle.
Business & Strategy
RTX spans three segments: Collins Aerospace (systems and aftermarket for civil/military aircraft), Pratt & Whitney (commercial and military engines plus MRO), and Raytheon (missiles, sensors, air-and-missile defense). The recent mix is shifting toward Raytheon as global munitions demand — AMRAAM, Stinger, Patriot — accelerates, lifting the defense weighting versus the commercial cycle.
Primary customers are the U.S. Department of Defense and allied/NATO governments, alongside commercial airframers (Boeing, Airbus) and the global airline aftermarket.
Revenue splits between long-cycle OEM production/development contracts and high-margin, recurring aftermarket (spares, overhaul, fleet management), the latter smoothing the commercial cycle. Government cost-plus and fixed-price programs anchor Raytheon and defense Collins/P&W.
Key cost drivers are aerospace-grade materials and rare-earth/critical-mineral inputs, skilled labor, and multi-year fixed-price contract execution risk.
RTX's moat rests on decades-long sole-source munitions franchises (AMRAAM, Stinger, Patriot), a vast installed engine base generating captive aftermarket revenue, and prohibitive certification/security barriers to entry. Switching costs and national-security sourcing rules make its incumbency effectively unassailable.
Monetary-Policy Sensitivity
- Low 0.30 beta dampens rate-driven multiple expansion
- Government-funded revenue is insensitive to consumer credit conditions
- $38.9B debt load benefits modestly from lower refinancing costs
As a low-beta, government-revenue defensive, RTX is far less rate-sensitive than cyclicals; a cut offers only marginal support via cheaper debt service and a modestly higher terminal-value discount. The stock's direction is dominated by defense-appropriations flow and commercial-aftermarket volume rather than the front end of the curve.
SWOT Analysis
- Perfect 4/4 EPS beat streak with +11.8% average surprise
- Sole-source missile franchises (AMRAAM, Stinger, Patriot) with expanding NATO co-production
- Low 0.30 beta and 81.5% institutional ownership provide stability
- Large captive commercial-aftermarket base funding defense investment
- Premium valuation (26.5x fwd P/E, 19.9x EV/EBITDA) leaves little margin for error
- Thin liquidity — quick ratio 0.65, $32.1B net debt
- Low 20.2% gross margin versus best-in-class aerospace peers
- Insiders net sellers of ~$26M into February strength
- $350B proposed U.S. defense package and NATO rearmament
- Doubling of Stinger and AMRAAM production capacity
- AI battlefield and connected-battlespace demand
- Domestic rare-earth reshoring de-risking the supply chain
- Fixed-price contract cost overruns and supply-chain inflation
- Geopolitical de-escalation compressing the defense premium
- Removal from the Russell 1000 Dynamic Index reducing passive demand
- Rare-earth/critical-mineral dependency on constrained sources
Catalysts & Event Risks
- Q3 2026Q2 2026 earnings
Next print tests the 4/4 beat streak and full-year guidance against the missile-demand ramp.
- Q3 2026AMRAAM European co-production decisions
Formal supplier qualification with NATO nations would expand capacity and de-risk backlog delivery.
- Q4 2026U.S. defense appropriations / SAVE America Act
Passage of the proposed $350B defense package would lift multi-year munitions demand.
- Q3 2026Stinger production doubling milestones
Progress with Diehl Defence on doubled Stinger output converts stated demand into booked revenue.
- 2026-12-31Buyback and dividend update
Capital-return cadence signals management confidence and supports per-share metrics.
The catalyst path is unusually dense and skewed positive — earnings execution, European co-production, and a landmark appropriations bill all cluster into H2 2026. The main risk to the setup is any geopolitical de-escalation that deflates the rearmament premium already embedded in the multiple.
Technical Analysis
RTX sits at the 81st percentile of its 52-week range, 6.4% below the $214.50 high and trading above both the 50-day ($180.60) and 200-day ($184.31) averages — a textbook uptrend. The 200-day near $184 is the first meaningful support and aligns with prior consolidation; the 52-week high at $214.50 is the immediate resistance to clear. With volume (4.4M) running below the 5.5M average, the advance is orderly rather than climactic. Risk-reward favors accumulating on pullbacks toward $184-190 rather than chasing into resistance.
Verdict
Macro context. The backdrop is a defense supercycle: rearmament budgets, Strait-of-Hormuz escalation, NATO capacity expansion, and a proposed $350B U.S. defense package are all lifting the sector, while low-beta defense names offer ballast against broader equity volatility.
RTX is the best-positioned prime for the missile-demand upcycle — a perfect 4/4 beat streak, +11.8% average surprise, sole-source franchises, and dense H2 2026 catalysts against a low-beta, institutionally-owned base. The offset is a full valuation (26.5x forward, 19.9x EV/EBITDA), only ~7% consensus upside, and executives selling ~$26M into February strength. We rate the shares ACCUMULATE with a $220 target, preferring to build the position on pullbacks toward the $184-190 support band rather than chase the 52-week high.
Data source: Yahoo Finance / yfinance · fetched 7/8/2026, 10:10:09 AM